Who has invested in Nucleus RadioPharma?

Mayo Clinic, Eclipse Ventures are named among the investors backing Nucleus RadioPharma.

Nucleus RadioPharma Funding: $62M Raised, Series A (2023)

Nucleus RadioPharma funding overview

Nucleus RadioPharma is based in Rochester, Minnesota. Nucleus RadioPharma has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Nucleus RadioPharma runs through 2023; nothing later has been disclosed. Investors on record include Mayo Clinic, Eclipse Ventures. 2 distinct backers are named across the disclosed rounds.

Nucleus RadioPharma at a glance

Total raised: $62M
Latest round: Series A
Latest round date: January 2023
Headquarters: Rochester, Minnesota
Notable investors: Mayo Clinic, Eclipse Ventures

Frequently asked about Nucleus RadioPharma funding

How much has Nucleus RadioPharma raised?: Nucleus RadioPharma has raised $62M in total disclosed funding across the rounds on record.
Who has invested in Nucleus RadioPharma?: Mayo Clinic, Eclipse Ventures are named among the investors backing Nucleus RadioPharma.
What was the latest Nucleus RadioPharma funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is Nucleus RadioPharma based?: Nucleus RadioPharma is based in Rochester, Minnesota.
When did Nucleus RadioPharma last raise?: The last disclosed Nucleus RadioPharma round closed in January 2023 at Series A.

Totals shown for Nucleus RadioPharma aggregate every disclosed round on file. To see how that compares, browse the companies in Rochester and the investors behind them below.

Nucleus RadioPharma Funding: $62M Raised, Series A (2023)

Nucleus RadioPharma funding overview

Nucleus RadioPharma at a glance

Frequently asked about Nucleus RadioPharma funding

Companies related to Nucleus RadioPharma (24)

Browse related funding lists (5)